Article
Nelfinavir is number 4 -- but should it bat cleanup, or lead off?
Journal of the International Association of Physicians in AIDS Care - 1 Jun 1997
Mascolini M
Abstract excerpt
Critical issues are addressed concerning when to use nelfinavir, a newly approved protease inhibitor. Because of a resistance mutation that occurs as a result of taking nelfinavir, the following questions arise: if resistance emerges in a patient naive to protease inhibitor therapy, will that per...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
